Artio closes $28M as it scales to save lives; latest funding brings Prairie Village startup’s investments to $74M
June 16, 2022 | Startland News Staff
Another hefty funding round for Artio Medical is expected to launch the startup’s commercial sales team in the U.S. and continue development of its best-in-class product pipeline, said founder Nicholas Franano.
Artio, a medical device company developing innovative products for the peripheral vascular, neurovascular, and cardiology markets, on Thursday announced the closing of $28 million in oversubscribed Series A2 and Series A3 financing, bringing the total amount raised to date to $74 million.
Funds will be used to support U.S. commercialization efforts for the recently cleared Solus Gold Embolization Device and to accelerate the development of Artio’s broad portfolio of products, including expanding the company’s engineering and manufacturing capabilities, Franano said in a press release.
Click here to read more about Artio’s $12 million funding infusion in 2021.
“We would like to thank our existing investors for their continued strong support and also welcome a new group of investors to Artio,” said Joseph McConnell, vice president of finance and business operations at Artio.
“We have the opportunity to do something really special here, to bring a new generation of medical devices to market with the potential to save lives, reduce disability, and improve the quality of life for millions of people,” McConnell continued. “This new capital will help Artio expand our team and scale our operations to deliver on that mission.”
Artio is currently developing ten products for the peripheral vascular market, including the Solus Gold and Solus Flex Embolization Devices for peripheral vessel occlusion and the Amplifi Vein Dilation System which is designed to prepare hemodialysis patients for successful arteriovenous fistula vascular access site creation.
Artio is also currently developing four products for the neurovascular market, including the Endura Embolization System comprising a detachable balloon and coils for the treatment of saccular brain aneurysms.
Click here to learn more about Artio’s portfolio of products.
2022 Startups to Watch
stats here
Related Posts on Startland News
Bloch faculty duo earn $200K grant toward effort to disrupt social media echo chambers
Editor’s note: The following story was originally published by the University of Missouri-Kansas City. Click here to read the original story. In the digital realm where algorithms reign supreme, Alex Krause Matlack and Bryan C. Boots from the UMKC Henry W. Bloch School of Management aim to create a tool that disrupts the social media landscape,…
Some 18th & Vine leaders say losing downtown stadium could have ‘a tremendously negative impact’
Editor’s note: The following story was published by KCUR, Kansas City’s NPR member station, and a fellow member of the KC Media Collective. Click here to read the original story or here to sign up for KCUR’s email newsletter. Businesses were split on their reaction to the vote on April 2 that rejected the extension of a 3/8th-cent sales tax…
Build a bigger bandwagon for women entrepreneurs, founders say; an isolated journey is too lonely
Representation of women in entrepreneurship is critically important, Vanessa Jupe told a crowd gathered this week at Union Station, emphasizing the power of exposure and leading by example to create a stronger, more diverse ecosystem. “If we don’t start businesses, then other women aren’t going to see that as a possibility,” said the founder and…
Designed with minimal parking, KC Current wants you to carpool to team’s next home match
A just-announced tech tool aims to help KC Current fans make sustainable and affordable transportation an easier choice on matchday as the hometown team continues a string of development wins at its new riverfront stadium. Current Carpool — a new feature from the free WAY TO GO trip planning and carpool matching app — connects…